Jeffrey Erickson

Company: Triumvira Immunologics Inc

Job title: Vice President

Seminars:

Next-Generation Cell Therapies Targeting Claudin: Overcoming Challenges & Improving Outcomes 2:45 pm

Showcasing the latest advancements in next-generation cell therapies targeting claudin, emphasizing novel approaches beyond CAR-T Understanding improvements in toxicity profiles and the durability of therapeutic responses in solid tumours Highlighting early clinical data and preclinical insights to illustrate the effectiveness and potential of these innovative therapiesRead more

day: Conference Day 2